logo

MLSS

Milestone Scientific·AMEX
--
--(--)
--
--(--)
1.10 / 10
Underperform

MLSS fundamentals are challenging, scoring only 1.1/10. Key weaknesses include negative asset-to-market value (-0.5007) and revenue-to-market value (-1.2347) differences, both in performance group 1. Net income margin on revenue is also negative (-0.1668), and ROA is deeply negative (-50.67%). Although interest coverage is healthy (15.48%), it is insufficient to offset other fundamental deficits, leading to an overall Underperform rating.

Fundamental(1.1)SentimentTechnical

Analysis Checks(4/10)

Revenue-MV
Value-1.23
Score2/3
Weight-0.29%
1M Return0.09%
ROA (%)
Value-50.67
Score0/3
Weight16.56%
1M Return-7.78%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight5.56%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight7.85%
1M Return-2.55%
Cash-UP
Value-0.06
Score2/3
Weight13.56%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-67.55
Score0/3
Weight16.56%
1M Return-7.78%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight6.27%
1M Return-1.95%
Asset-MV
Value-0.50
Score0/3
Weight10.51%
1M Return-3.57%
Cash-MV
Value-3.20
Score1/3
Weight14.90%
1M Return-5.64%
Net profit / Total profit (%)
Value100.00
Score1/3
Weight8.51%
1M Return-2.89%
Is MLSS fundamentally strong?
  • MLSS scores 1.10/10 on fundamentals and holds a Premium valuation at present. Backed by its -110.51% ROE, -74.66% net margin, -2.97 P/E ratio, 8.13 P/B ratio, and -50.00% earnings growth, these metrics solidify its Underperform investment rating.